Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Osteoporosis Drugs Found To Be Equally Effective – AHRQ Report

Executive Summary

An Agency for Healthcare Research & Quality draft report on osteoporosis treatments found that bisphosphonates are not demonstrably superior to less costly treatments

You may also be interested in...



Metformin Is Most Effective Diabetes Drug At Reducing BMI – AHRQ Report

Metformin is more effective than thiazolidinediones and second generation sulfonylureas in decreasing weight and body mass index in type 2 diabetes patients, according to an Agency for Healthcare Research & Quality 1draft report

Metformin Is Most Effective Diabetes Drug At Reducing BMI – AHRQ Report

Metformin is more effective than thiazolidinediones and second generation sulfonylureas in decreasing weight and body mass index in type 2 diabetes patients, according to an Agency for Healthcare Research & Quality 1draft report

Lilly’s Forteo Not A “Rational Choice” For Most Osteoporosis, Analysis Finds

Lilly's osteoporosis treatment Forteo (teriparatide) would be cost-effective if the product were 60% cheaper and used sequentially with Merck's Fosamax (alendronate), according to a study published in the Archives of Internal Medicine

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047278

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel